No abstract

Exposing unmasked US Army recruits to elevated levels of o-chlorobenzylidene malononitrile (CS tear gas) during Mask Confidence Training (MCT) increases the risk of Acute Respiratory Illness (ARI) diagnosis in the period following CS exposure when compared to the period before exposure. All Army Activities Message (ALARACT) 051/2013 was implemented in March 2013 to reduce CS exposure concentrations during MCT and associated ARI rates. This observational, prospective cohort studied CS exposures and associated ARI health outcomes after implementation of ALARACT 051/2013 in 5 298 recruits attending US Army Basic Combat Training (BCT). These data indicate a 10-fold reduction (p<0.001) in CS exposure concentrations; recruit exposures ranged from 0.26 -2.78 mg/m 3 ( =1.04 mg/m 3 ) and chamber operator exposures from 0.05 -2.22 mg/m 3 ( =1.05 mg/m 3 ). The overall risk of ARI diagnosis following CS exposure also decreased when compared to period before exposure (RR=1.79, 95%CI=1.29, 2.47) resulting in 26.85% (95%CI=-0.17, 0.54) intervention effectiveness. Post-chamber ARI rates were dependent upon CS exposure concentration (p=0.02), and pre/post-chamber ARI rate ratios were significantly elevated at all concentration categories higher than the Threshold Limit Value Ceiling (TLV-C) (0.39 mg/m 3 ). Results support previous research suggesting risk of ARI diagnosis after CS exposure is positively associated with CS concentration.

This study was conducted among U.S. Army soldiers to evaluate the association between exposure to o-chlorobenzylidene malononitrile (CS riot control agent) and urinary metabolite 2-chlorohippuric acid (CHA) detected in test subjects (n = 87) after completion of Mask Confidence Training. CS exposures ranged 0.086-4.9 mg/m³ ([Formula: see text] = 2.7 mg/m³). CHA levels (corrected for creatinine) at 2-, 8-, 24-, and 30-hr post-exposure resulted in ranges of 94.6-1120 µg/g-cr ([Formula: see text] = 389 µg/g-cr), 15.80-1170 µg/g-cr ([Formula: see text] = 341 µg/g-cr), 4.00-53.1 µg/g-cr ([Formula: see text] = 19.3 µg/g-cr), and 1.99-28.4 µg/g-cr ([Formula: see text] = 10.6 µg/g-cr), respectively. Spearman's correlation revealed CHA levels strongly correlated with time sampled (r = -0.748, p < 0.05) and weakly correlated with CS concentration (r = 0.270, p < 0.05). A linear relationship was observed between CHA, CS concentration, and time of urine sample according to the following regression equation: ln(CHA, μg/g-cr) = 5.423 + 0.316 (CS conc., mg/m³) - 0.002 (time sampled), (R = 0.910, R² = 0.827, p < 0.05). This relationship suggests that CHA has the potential to be an effective retrospective indicator of CS exposure in future biomarker developments.

No abstract

No abstract